Piper Sandler Maintains Overweight on OPKO Health, Lowers Price Target to $3
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Edward Tenthoff maintains an Overweight rating on OPKO Health (NASDAQ:OPK) but lowers the price target from $5 to $3.
July 18, 2024 | 11:46 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Piper Sandler maintains an Overweight rating on OPKO Health but lowers the price target from $5 to $3.
The lowered price target from $5 to $3 suggests a less optimistic outlook for OPKO Health's stock performance, which could lead to a short-term decline in the stock price despite the maintained Overweight rating.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100